Dong Ju, Wang Ying, Qian Qin, Wu Juan, Yang Dongqing, Liu Deye
Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
J Ethnopharmacol. 2024 Oct 28;333:118426. doi: 10.1016/j.jep.2024.118426. Epub 2024 Jun 4.
Realgar (AsS or AsS) is a traditional Chinese medicine (TCM) containing arsenic. Existing studies have shown that it has genotoxicity under long-term use with large doses. Niuhuang Jiedu (NHJD) is a Chinese medicine prescription containing realgar and seven other TCMs. Whether the multiple TCMs combination in NHJD can reduce the genotoxicity induced by realgar in equivalent doses is still unknown.
To research the effect of NHJD on realgar's genotoxicity and the possible mechanism involved based on the arsenic methylation metabolic pathway.
Six groups (control, realgar (0.8 g/kg), NHJD (12.48 g/kg), as well as Glycyrrhiza uralensis Fisch (GU), Scutellaria baicalensis Georg (SB), Rheum palmatum L (RP) plus equivalent doses of realgar, respectively) were set up. ICR mice were intragastric administered for 12 weeks. First, genotoxicology tests were conducted to evaluate the effect of NHJD, GU, SB, and RP on reducing realgar's genotoxicity. The inorganic arsenic (iAs), dimethyl arsenic acid (DMA), and monomethyl arsenic acid (MMA) were determined by HPLC-AFS, and the iAs%, MMA%, DMA%, primary methylation index (PMI), etc. Were calculated. Meanwhile, the S-adenosyl methionine (SAM) and arsenate reductase (ARR) levels, the arsenic (+3)methyltransferase (AsMT), purine-nucleoside phosphorylase (PNP), glutathione S-transfer omega1 (GSTO1) gene expression were detected, aimed to explore the possible alleviation mechanisms of NHJD.
The combination of multiple TCMs in NHJD decreased the levels of MN‰, SPA%, and DNA damage caused by realgar, with similar effects observed when SB, RP, and GU were used separately with realgar. Notably, the iAs% significantly decreased, while DMA% and PMI notably increased in the NHJD and realgar + SB (or RP) groups compared to the realgar-only group (P < 0.05). Increases in SAM and ARR levels were observed across various groups, but only the ARR increase in the NHJD group was statistically significant. Moreover, significant increases in AsMT mRNA and GSTO1 mRNA were noted in the NHJD group, and PNP mRNA levels significantly rose in the realgar + SB group.
This study revealed that NHJD could attenuate the genotoxic effects of realgar. The botanicals SB, RP, and GU within NHJD may be key contributors to this effect. Enhancements in arsenic methylation capabilities through increased levels of SAM and ARR and elevated gene expressions of AsMT, PNP, and GSTO1 suggest potential mechanisms behind these findings.
雄黄(AsS或AsS)是一种含砷的传统中药。现有研究表明,长期大剂量使用时它具有遗传毒性。牛黄解毒片(NHJD)是一种含有雄黄和其他七种中药的中药方剂。NHJD中多种中药组合是否能降低等量雄黄诱导的遗传毒性尚不清楚。
基于砷甲基化代谢途径研究NHJD对雄黄遗传毒性的影响及可能机制。
设置六组(对照组、雄黄(0.8 g/kg)、NHJD(12.48 g/kg),以及甘草(GU)、黄芩(SB)、大黄(RP)分别加等量雄黄)。对ICR小鼠进行12周的灌胃给药。首先,进行遗传毒理学试验以评估NHJD、GU、SB和RP对降低雄黄遗传毒性的作用。采用高效液相色谱-原子荧光光谱法测定无机砷(iAs)、二甲基砷酸(DMA)和一甲基砷酸(MMA),并计算iAs%、MMA%、DMA%、初级甲基化指数(PMI)等。同时,检测S-腺苷甲硫氨酸(SAM)和砷酸盐还原酶(ARR)水平,以及砷(+3)甲基转移酶(AsMT)、嘌呤核苷磷酸化酶(PNP)、谷胱甘肽S-转移酶ω1(GSTO1)基因表达,旨在探讨NHJD可能的缓解机制。
NHJD中多种中药的组合降低了雄黄引起的微核率(MN‰)、精子畸形率(SPA%)和DNA损伤水平,单独使用SB、RP和GU与雄黄时观察到类似效果。值得注意的是,与仅使用雄黄的组相比,NHJD组和雄黄+SB(或RP)组的iAs%显著降低,而DMA%和PMI显著升高(P<0.05)。各实验组均观察到SAM和ARR水平升高,但只有NHJD组ARR的升高具有统计学意义。此外,NHJD组AsMT mRNA和GSTO1 mRNA显著升高,雄黄+SB组PNP mRNA水平显著升高。
本研究表明NHJD可减轻雄黄的遗传毒性作用。NHJD中的植物药SB、RP和GU可能是这一作用的关键贡献者。通过增加SAM和ARR水平以及提高AsMT、PNP和GSTO1的基因表达来增强砷甲基化能力,提示了这些发现背后的潜在机制。